We use cookies to make your experience better
Furthermore, ongoing research and development activities would bring next-generation GLP-1 therapies, oral formulations, and dual incretin therapies
The primary endpoint, the between-group change in left ventricular mass, demonstrated that tirzepatide significantly reduced left ventricular mass and paracardiac adipose tissue compared to placebo, with reductions in weight loss
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals
I started my weight-loss journey at 288 pounds before my gastric sleeve surgery, and even after surgery, I hit a prolonged stall
"I would do whatever I needed to do to avoid that mirror, because it made me feel so bad." But after losing 80 pounds (and counting), the 35-year-old cardiac tech from Oklahoma can't wait for this year's Thanksgiving Day dinner